Helen Feilden

1.1k total citations
11 papers, 829 citations indexed

About

Helen Feilden is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Helen Feilden has authored 11 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 2 papers in Organic Chemistry. Recurrent topics in Helen Feilden's work include Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers) and Chemical Synthesis and Analysis (2 papers). Helen Feilden is often cited by papers focused on Receptor Mechanisms and Signaling (3 papers), Neuropeptides and Animal Physiology (3 papers) and Chemical Synthesis and Analysis (2 papers). Helen Feilden collaborates with scholars based in United Kingdom, Netherlands and France. Helen Feilden's co-authors include Ronald Palin, A. Bom, John K. Clark, David C. Rees, Ming‐Qiang Zhang, Alan W. Muir, J. van Egmond, Mark Philip Bradley, E.J. MacLean and Donald Stevenson and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Helen Feilden

11 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Feilden United Kingdom	9	406	201	196	195	176	11	829
Ronald Palin United Kingdom	11	425 1.0×	214 1.1×	231 1.2×	229 1.2×	190 1.1×	19	944
A. Bom Netherlands	17	879 2.2×	465 2.3×	306 1.6×	203 1.0×	420 2.4×	42	1.6k
Gregory J. Pacofsky United States	11	228 0.6×	97 0.5×	165 0.8×	210 1.1×	86 0.5×	14	616
Gary J. Tarver United Kingdom	12	130 0.3×	71 0.4×	218 1.1×	365 1.9×	55 0.3×	15	725
Donald Stevenson United States	8	113 0.3×	56 0.3×	131 0.7×	113 0.6×	50 0.3×	17	386
Edward J. Hutchinson United Kingdom	8	105 0.3×	54 0.3×	109 0.6×	116 0.6×	41 0.2×	16	326
Ross C. Terrell United States	11	110 0.3×	63 0.3×	233 1.2×	758 3.9×	23 0.1×	19	1.2k
Julia M. Adam United Kingdom	6	98 0.2×	53 0.3×	72 0.4×	61 0.3×	40 0.2×	7	257
Jaemoon Lee South Korea	17	50 0.1×	51 0.3×	212 1.1×	417 2.1×	47 0.3×	64	806
K. Fukushima Japan	13	59 0.1×	52 0.3×	86 0.4×	193 1.0×	23 0.1×	47	534

Countries citing papers authored by Helen Feilden

Since Specialization

Citations

This map shows the geographic impact of Helen Feilden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Feilden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Feilden more than expected).

Fields of papers citing papers by Helen Feilden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Feilden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Feilden. The network helps show where Helen Feilden may publish in the future.

Co-authorship network of co-authors of Helen Feilden

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Feilden. A scholar is included among the top collaborators of Helen Feilden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Feilden. Helen Feilden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Maclean, John, Darren Edwards, Katy L. Everett, et al.. (2011). Identification of potent, soluble, and orally active TRPV1 antagonists. Bioorganic & Medicinal Chemistry Letters. 21(8). 2559–2563. 19 indexed citations

2.

Kiyoi, Takao, et al.. (2011). Stereoselective synthesis of tetrahydro-2H-[2]benzopyrano[3,4-c]pyrrol-3-ones and related compounds as precursors of serotonin 5-HT2C receptor agonists. Tetrahedron Letters. 52(27). 3421–3425. 2 indexed citations

3.

Palin, Ronald, John K. Clark, Louise Evans, et al.. (2009). Rapid access towards follow-up NOP receptor agonists using a knowledge based approach. Bioorganic & Medicinal Chemistry Letters. 19(22). 6441–6446. 3 indexed citations

4.

Palin, Ronald, A. Bom, John K. Clark, et al.. (2006). Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties. Bioorganic & Medicinal Chemistry. 15(4). 1828–1847. 17 indexed citations

5.

Palin, Ronald, John K. Clark, Jean E. Cottney, et al.. (2004). Synthesis and SAR studies of 3-phenoxypropyl piperidine analogues as ORL1 (NOP) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 15(3). 589–593. 10 indexed citations

6.

Bom, A., Mark Philip Bradley, John K. Clark, et al.. (2002). A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host The discovery of Org 25969 is the result of teamwork with contributions from a number of scientists both inside Organon and outside the company. We would like in particular to acknowledge the following scientists for their invaluable contributions: E. Hutchinson, D. Stevenson, R. Roy, and J. Pick for scaling-up the synthesis; F. Hope, S. Miller, and R. Mason for various in vitro and in vivo pharmacological testing; R. Watson, B. Montgomery, P. Desmond, and A. Osprey for all their analytical effort; and R. McGuire and J. Mestres for graphical presentation of the X-ray crystal structure of the Org 25969–rocuronium complex (Figure 3). We would also like to thank Prof. A. Cooper of Glasgow University who has critically reproduced our calorimetry data of Org 25969–rocuronium complexation (Figure 2).. Angewandte Chemie International Edition. 41(2). 265–265. 375 indexed citations

7.

Bom, A., Mark Philip Bradley, John K. Clark, et al.. (2002). A Novel Concept of Reversing Neuromuscular Block: Chemical Encapsulation of Rocuronium Bromide by a Cyclodextrin-Based Synthetic Host. Angewandte Chemie. 114(2). 275–280. 173 indexed citations

8.

Adam, Julia M., David Jonathan Bennett, A. Bom, et al.. (2002). Cyclodextrin-Derived Host Molecules as Reversal Agents for the Neuromuscular Blocker Rocuronium Bromide: Synthesis and Structure−Activity Relationships. Journal of Medicinal Chemistry. 45(9). 1806–1816. 190 indexed citations

9.

Bom, A., et al.. (2001). Chemical chelation as a novel method of NMB reversal - discovery of Org 25969. European Journal of Anaesthesiology. 18(Supplement 23). 99–99. 8 indexed citations

10.

Belelli, Delia, David Jonathan Bennett, Anna Casula, et al.. (2001). α-Amino Acid Phenolic Ester Derivatives: Novel Water-Soluble General Anesthetic Agents Which Allosterically Modulate GABA_A Receptors. Journal of Medicinal Chemistry. 44(22). 3582–3591. 23 indexed citations

11.

Howes, Peter D., Anne Cleasby, Helen Feilden, et al.. (1999). 4-Acetylamino-3-(imidazol-1-yl)-benzoic acids as novel inhibitors of influenza sialidase. European Journal of Medicinal Chemistry. 34(3). 225–234. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact